Welcome : Guest

DIABETES DIAGNOSTICS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ by the following Product Segments: Continuous Glucose Monitoring (CGM) Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 58 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
Acon Laboratories, Inc.
AgaMatrix, Inc.
Alere Inc.
Animas Corporation

Click here to request a full list of companies covered in the report...

Code: MCP-3404
Price: $4950
Companies: 58
Pages: 429
Date: October 2016
Market Data Tables: 141
  Status: * New Report



TABLE OF CONTENTS


  DIABETES DIAGNOSTICS (Complete Report) Pages : 429   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global
  Diabetes Epidemic.....II-1
1$100
   Evolution of Diabetes Testing over the Years with Key Features in Each Period.....II-21$100
   Growth Drivers in a Nutshell.....II-31$100
   Alarming Levels of Diabetes Incidence Worldwide Drives Strong Demand for Diabetes
  Diagnostic Devices.....II-4
1$100
   Table 1: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart).....II-51$350
   Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart).....II-6

Table 3: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart).....II-6
1$350
   Table 4: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender: 2015 (includes corresponding Graph/Chart).....II-7

Table 5: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart).....II-7
1$350
   Table 6: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart).....II-81$350
   Diabetes: One of the Leading Causes of Death.....II-9
Table 7: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region: 2015 (includes corresponding Graph/Chart).....II-9
1$350
   Etiological Factors Causing Diabetes.....II-10
Diabetes Incidence and Prevalence by Region/Country.....II-10
North America.....II-10
United States.....II-10
Canada.....II-10
Mexico.....II-10
Europe.....II-10
1$100
   Asia-Pacific.....II-11
Southeast Asian Region.....II-11
Western Pacific Region.....II-11
South & Central America.....II-11
1$100
   Africa.....II-12
Global Market Outlook.....II-12
2$200
   Developing Countries Continue to Offer Significant Growth Opportunities.....II-14
China: An Untapped Goldmine for Diabetes Diagnostic Devices.....II-14
1$100
   Rising Diabetic Populace Spurs Growth in the Indian Market.....II-15 1$100
   Table 8: Global Diabetes Diagnostics Market - Geographic Regions Ranked by CAGR (Value) for 2015-2022: China, India, Germany, UK, US, France, Italy, Russia, Spain, Canada, and Japan (includes corresponding Graph/Chart).....II-161$350
   Major Pharma Players Dominate Diabetes Diagnostics Market.....II-17
Competition with Local Pharma Companies Intensifies in Regional Markets.....II-17
1$100
   Continuous Glucose Monitoring Systems (CGMS): Competitive Landscape.....II-18
Table 9: Leading Products/Brands in the Global Continuous Glucose Monitoring Market (2015): Percentage Breakdown of Value Sales for Dexcom G4 Platinum, Dexcom Seven Plus, Free Style Navigator, Guardian Real Time, Minimed Paradigm Revel and Others (includes corresponding Graph/Chart).....II-18
1$350
   Medtronic Dominates the Global CGM Devices Market.....II-19
Leading Companies Continue to Focus on CGM Innovations.....II-19
1$100
   Leading Companies and their CGM Innovations.....II-20
CGM Companies Outsmart Each Other with Innovative Marketing Offers.....II-20
1$100
   The Big Four in the Global Blood Glucose Monitoring (BGM) Devices Market.....II-21
Table 10: Leading Players in the Global Blood Glucose Monitoring Devices Market (2015): Percentage Market Share Breakdown for Abbott, Bayer, LifeScan, Roche, and Others (includes corresponding Graph/Chart).....II-21
Quality Products at Low Prices: Mantra for Success in the Marketplace.....II-21
1$350
   After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move.....II-22
Competition in the HbA1c Testing Devices Market.....II-22
1$100
   Table 11: Leading Players in the Global HbA1c Reagent Market (2015E): Percentage Breakdown of Revenues for Siemens and Others (includes corresponding Graph/Chart).....II-23
Select Laboratory-based HbA1c Testing Products/Analyzers.....II-23
4$350
   Select Point of Care HbA1c Testing Products/Analyzers.....II-272$200
   Major POC HbA1c Tests in the Market.....II-29
Select HbA1c POC Tests in the Market - A Comparison.....II-29
Product Innovation is the Name of the Game for HbA1c Testing Device Companies.....II-29
1$100
   Manufacturers Focus on Offering Products for Developing Markets.....II-301$100
   Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for
  Minimally-Invasive CGM Devices.....II-31
1$100
   CGM Market Gradually Breaks through Barriers to Adoption.....II-32 1$100
   Table 12: Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart).....II-33
Intensive Care Units: A Highly Promising Market for CGMs.....II-33
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c
  Testing Devices.....II-33
2$350
   Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c
  Devices.....II-35
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption.....II-35
2$200
   Home HbA1c Testing: Lack of Reimbursement Coverage & Accuracy Concerns Affect
  Adoption.....II-37
1$100
   Glycated Albumin: A Potential Threat to HbA1c?.....II-381$100
   Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap.....II-391$100
   Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?.....II-40
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin
  Variants.....II-40
1$100
   ESC and ADA Release Revised Guidelines for HbA1c Testing.....II-411$100
   Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues
  to Dominate Sales.....II-42
1$100
   Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring
  Systems.....II-43
1$100
   Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand.....II-44
Key Trends in the Glucose Meter/Monitoring Systems.....II-44
1$100
   Smartphone Penetration Favors SMBG Market.....II-45 1$100
   Table 13: Smartphone Penetration Rate (%) for Select Countries Worldwide as a Percentage of Population Owning a Phone: 2016 (includes corresponding Graph/Chart).....II-461$350
   Demand for BGM Products to Witness Varying Patterns in Developed and Developing
  Markets.....II-47
Barriers to Adoption of New Technology in BGM Products.....II-47
1$100
   Accuracy Issues Plague Blood Glucose Meters Market.....II-481$100
   Advancements in Glucose Monitoring Devices Offers a New Ray of Hope.....II-491$100
   Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped
  Potential.....II-50
1$100
   Table 14: Number of Undiagnosed Individuals (20-79 Years in Million) Living with Diabetes and Proportion (%) Worldwide by Region: 2015 (includes corresponding Graph/Chart).....II-51
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases.....II-51
1$350
   Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand
  for Diagnostic Devices.....II-52
Heart Disease.....II-52
1$100
   Stroke.....II-53
High Blood Pressure.....II-53
Blindness.....II-53
Kidney Disease.....II-53
Nerve Disease.....II-53
Amputations.....II-53
Dental Disease.....II-53
Pregnancy.....II-53
Microvascular Complications (Small Blood Vessel Damage).....II-53
Retinopathy.....II-53
1$100
   Diabetic Neuropathy.....II-54
Nephropathy.....II-54
Macrovascular Complications (Large Blood Vessel Damage).....II-54
Cardiac Problems.....II-54
Hypertension (High Blood Pressure).....II-54
Infections.....II-54
Impotence.....II-54
1$100
   Pregnancy Complications.....II-55
Other Complications Resulting from Diabetes.....II-55
Obesity.....II-55
Obsessive Compulsive Disorder.....II-55
Foot Ulcers.....II-55
1$100
   Dementia.....II-56
Hypoglycemia.....II-56
1$100
   Diabetic Ketoacidosis.....II-57
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular
  Complications.....II-57
1$100
   High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market
  Expansion.....II-58
1$100
   Demographic Statistics of the Global Aging Populace: Unfurling the Market
  Potential.....II-59
Table 15: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-59

Table 16: Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart).....II-59
1$350
   Table 17: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-601$350
   Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis.....II-61
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market.....II-61
1$100
   Table 18: Global Per Capita Healthcare Spending (in US$) by Geographic Region for the Year 2014 (includes corresponding Graph/Chart).....II-621$350
   Table 19: Healthcare Spending as % of GDP by Geographic Region (2016E) (includes corresponding Graph/Chart).....II-63

Table 20: Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart).....II-63
1$350
   Rising Expenditure on Diabetes Management Drives the Need for Timely Diagnosis and
  Diagnostic Devices.....II-64
Table 21: Global Prevalence of Diabetes and Expenditure on its Management by Region (2015 & 2040P): Number of People Diagnosed with Diabetes in the Age Group 20-79 Years (Billions) and Expenditure on Management of Diabetes and its Complications (in US$ Billions) (includes corresponding Graph/Chart).....II-64
1$350
   Table 22: Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart).....II-651$350
   Table 23: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart).....II-661$350
   Table 24: Health Expenditure on Diabetes by Region: Average Diabetes-Related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart).....II-671$350
   Table 25: Health Expenditure on Diabetes (2015): Average Diabetes-Related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart).....II-681$350
   Increasing Obesity Levels Underpins Market Growth.....II-69
Table 26: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart).....II-69
1$350
   Table 27: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-701$350
   mHealth Solutions for Diabetes Diagnosis.....II-71
Non-invasive Wearable Glucose Testing Devices.....II-71
1$100
   Apple and Google to Develop Wearable Continuous Glucose Monitors.....II-721$100
   GlySens Focus on Developing Implantable Continuous Glucose Monitor.....II-73
Researchers Develop Prototype of Wearable Closed-Loop System.....II-73
1$100
   Glucovation SugarSenz: Cloud Enabled CGM Device.....II-741$100
   EyeSense to Develop Affordable CGM Device.....II-75
Insulin Pump with CGM Sensor.....II-75
Glucose Monitoring through Smartphone Apps: The Latest Breakthrough.....II-75
1$100
   Table 28: No. of Diabetic Patients Worldwide and No. of App-Using Patients (in Million): 2014 & 2018P (includes corresponding Graph/Chart).....II-76
Bar-Illan University of Israel’s Research for Non-invasive, Wearable Glucose Testing
  Device.....II-76
1$350
   Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring.....II-77
EMG 1000: Needle-free Device for Glucose Monitoring.....II-77
1$100
   Glucase: Smartphone Case with Glucose Testing Kit.....II-78
Painless Diabetes Monitoring Using NFC Technology.....II-78
1$100
   GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels.....II-79
ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes.....II-79
1$100
   Sugar.IQ App: Powerful Features for Diabetics.....II-80
NoStrip™ Technology: Eliminating Need for Individual Test Strips.....II-80
Artificial Pancreas System (APS): The Future of Diabetes Care.....II-80
1$100
   A Prelude.....II-81
Continuous Glucose Monitoring (CGM) Systems.....II-81
1$100
   Hemoglobin A1c (HbA1c) Test.....II-82
HbA1c Test Types.....II-82
HbA1c Laboratory Testing.....II-82
1$100
   Analytical Techniques Used for Quantifying HbA1c in Labs.....II-83
Standardization of HbA1c Results.....II-83
1$100
   Table 29: CAP Accuracy Grading for HbA1c Measurements (2007-2013).....II-84
HbA1c Point of Care Testing & Self-Monitoring.....II-84
1$350
   Blood Glucose Testing Devices.....II-85
Blood Glucose Monitor/Meter.....II-85
Diabetes Testing Supplies.....II-85
Blood Glucose Test Strips.....II-85
Lancet.....II-85
Lancet Device.....II-85
Reagent Strips.....II-85
Reagent Tablet.....II-85
1$100
   Diabetes: A Chronic Body Disorder.....II-86
Diabetes Symptoms.....II-86
Types of Diabetes.....II-86
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM).....II-86
1$100
   Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM).....II-871$100
   Roche Launches Accu-Chek Guide BGM System.....II-88
Cellnovo Introduces Manual Input Feature to CGM Users.....II-88
ACON to Offer New Glucose Meter System with On Call® Products.....II-88
Senseonics Receives CE Mark Approval for Eversense® CGM System.....II-88
Ascensia Receives CE Mark Approval for CONTOUR Glucose Monitoring Systems.....II-88
Intuity Medical Receives FDA Clearance for its POGO® System.....II-88
Medtronic plc Reports Favorable Study Data on its MiniMed® Insulin Pump.....II-88
1$100
   Nemaura Medical Receives CE Approval for sugarBEAT® CGM System.....II-89
ACON Laboratories Launches OptiLance™ Push-Button Safety Lancets.....II-89
LabStyle Innovations Launches Smartphone-powered Glucometer Dario.....II-89
J&J’s LifeScan Introduces OneTouch Verio System With Easy-to-read Results.....II-89
Abbott Receives Approval from TGA for FreeStyle® Libre System.....II-89
Dnurse Technology Announces CE Approval for Dnurse Glucose Meter and App.....II-89
FDA Approves Animas® Vibe® Insulin Pump and CGM System for Use in Children.....II-89
1$100
   Owen Mumford Launches Touch-Activated Lancet Unistik® Touch.....II-90
Dexcom’s G5® Mobile CGM System Receives CE Mark.....II-90
Dexcom Receives FDA Approval for its G5® Mobile CGM System.....II-90
Abbott Receives FDA Approval for OTC Glucose Monitor.....II-90
ARKRAY Unveils New Instruments for HbA1c Measurement.....II-90
Roche Introduces New Cobas C513 Analyser.....II-90
ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests.....II-90
1$100
   ARKRAY Unveils CinQ HbA1c Range of Reagent Kit.....II-91
Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer.....II-91
ARKRAY Releases PocketChem A1c HbA1c Analyzer.....II-91
Bio-Rad Bags FDA Approval for D-100™ System for A1c Testing.....II-91
Bio-Rad’s VARIANT™ II TURBO HbA1c Kit – 2.0 Receives FDA Approval for Use in Diabetes
  Diagnosis.....II-91
Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test.....II-91
1$100
   Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS® Chemistry Products HbA1c
  Reagent Kit.....II-92
FDA Approves Animas® Vibe™ insulin pump and CGM for Adults.....II-92
CVS/pharmacy Launches its Brand of FDA-Approved Advanced Glucose Meter.....II-92
Dexcom Receives FDA Approval for Remote Blood Sugar Monitoring Tool.....II-92
Abbott’s FreeStyle Libre System Receives EU Approval.....II-92
iHealth Lab Launches iHealth Align.....II-92
Dexcom Receives FDA Approval for Real-time Professional CGM.....II-92
1$100
   Nipro Diagnostics Receives FDA Clearance for TRUE METRIX™ & TRUE METRIX™ PRO.....II-93
LifeScan Launches OneTouch Verio Glucose Monitoring Device.....II-93
Omnis Health Launches EmbraceEVO™ Blood Glucose Meter.....II-93
GE Healthcare Announces Validation of GE200 Blood Glucose Meter.....II-93
Sanofi Launches Blood Glucose Monitor that Offers HbA1c Estimates.....II-93
Beckman Coulter Introduces Next-Generation Hemoglobin A1c.....II-93
ARKRAY Unveils ADAMS A1c mini Glycated- Hemoglobin Analyzer.....II-93
1$100
   Axis-Shield Introduces HbA1c Turbidimetric Immunoassay.....II-94
ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer.....II-94
Sebia Unveils Capillarys HbA1c Assay.....II-94
Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test.....II-94
1$100
   Ypsomed Collaborates with Novo Nordisk for Insulin Pumps.....II-95
Senseonics Holdings Signs Exclusive Distribution Agreement with Roche.....II-95
Siemens Healthcare Rebrands as Siemens Healthineers.....II-95
Cellnovo and Roche Sign Agreement on Blood Glucose Monitors.....II-95
Bayer to Sell Diabetes Care Business to Panasonic Healthcare.....II-95
Sinocare to Acquire PTS Diagnostics.....II-95
1$100
   Abbott Inks Definitive Agreement to Take over Alere.....II-96
Decision Diagnostics Enters into R&D Agreement with Korean Manufacturer.....II-96
Medtronic Collaborates with Qualcomm for Disposable CGM.....II-96
Integrity Applications Enters into Distribution Agreements with LifeCaring Technologies
  and Guangzhou Guang Yuan Biological.....II-96
Insulet Corporation Extends Agreement with Abbott.....II-96
Decision Diagnostics Acquires Genstrip from Shasta Technologies.....II-96
1$100
   Abbott Diabetes Care, Inc. (US).....II-97
Acon Laboratories, Inc. (US).....II-97
AgaMatrix, Inc. (US).....II-97
1$100
   Alere Inc. (US).....II-98
Animas Corporation (US).....II-98
1$100
   Apex Biotechnology Corporation (Taiwan).....II-99
ARKRAY, Inc. (Japan).....II-99
1$100
   Ascensia Diabetes Care Holdings AG (Switzerland).....II-100
A.Menarini Diagnostics Ltd. (UK).....II-100
B. Braun Melsungen AG (Germany).....II-100
1$100
   Becton, Dickinson and Company (US).....II-1011$100
   Bayer Healthcare Diabetes Care (US).....II-102
Beckman Coulter, Inc. (US).....II-102
1$100
   Bio-Rad Laboratories (US).....II-103
BIONIME Corporation (Taiwan).....II-103
1$100
   Diazyme Laboratories Inc. (US).....II-104
Dexcom, Inc. (US).....II-104
EKF Diagnostics Holdings Plc (UK).....II-104
1$100
   HemoCue® AB (Sweden).....II-105
Infopia Co., Ltd. (South Korea).....II-105
1$100
   LifeScan, Inc. (US).....II-106
Medtronic MiniMed, Inc. (US).....II-106
Nova Biomedical Corporation (US).....II-106
1$100
   PTS Diagnostics (US).....II-107
Roche Diagnostics (Switzerland).....II-107
1$100
   Sanofi S.A. (France).....II-1081$100
   Sanwa Kagaku Kenkyusho Co, Ltd. (Japan).....II-109
Siemens Healthineers (Germany).....II-109
1$100
   Taidoc Technology Corporation (Taiwan).....II-110
Tandem Diabetes Care, Inc. (US).....II-110
Terumo Corporation (Japan).....II-110
1$100
   Tosoh Bioscience, Inc. (US).....II-111
Trinity Biotech plc (Ireland).....II-111
Trividia Health, Inc. (US).....II-111
1$100
   Ypsomed AG (Switzerland).....II-1121$100
   Table 30: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1131$350
   Table 31: World Historic Review for Diabetes Diagnostics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1141$350
   Table 32: World 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-1151$350
   By Product Segment:.....II-116
Table 33: World Recent Past, Current & Future Analysis for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-116
1$350
   Table 34: World Historic Review for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1171$350
   Table 35: World 14-Year Perspective for CGM Systems by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-1181$350
   Table 36: World Recent Past, Current & Future Analysis for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1191$350
   Table 37: World Historic Review for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1201$350
   Table 38: World 14-Year Perspective for HbA1c Testing Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-1211$350
   Table 39: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1221$350
   Table 40: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1231$350
   Table 41: World 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-1241$350
   A. Market Analysis.....III-1
The US: The Largest Diabetes Diagnostics Market Worldwide.....III-1
Diabetes: A Leading Cause of Death in the US.....III-1
1$75
   Table 42: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart).....III-2

Table 43: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s).....III-2
Aging Population: A Key Growth Factor.....III-2
1$200
   Table 44: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-3

Table 45: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-3

Table 46: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-3
1$200
   Table 47: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-4
Economic Burden of Diabetes.....III-4
1$200
   Table 48: Health Expenditure (in US$ Billion) on Diabetes in the US: 2015 & 2040 (includes corresponding Graph/Chart).....III-5
Healthcare Reform Legislation: Impact on Diabetes Diagnostics.....III-5
1$200
   HbA1c Testing for Diabetes Detection Gains Support.....III-6
ADA Recommends HbA1c Test for Diabetes Diagnosis.....III-6
ADA Recommends New Guidelines for HbA1c Testing for Certain Patients.....III-6
1$75
   HbA1c – Increasingly Moving into Physician’s Office.....III-7
Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening &
  Management.....III-7
1$75
   Growing Inclination towards CLIA-Waived Tests.....III-8
Wearable and Non-Invasive Glucose Monitoring Devices Favored.....III-8
FDA Guidance for Blood Glucose Meters.....III-8
1$75
   Emerging "Grey Market" for Testing Strips.....III-91$75
   Competitive Landscape.....III-10
US Near Patient HbA1c Testing: A Highly Consolidated Market.....III-10
Table 49: Leading Players in the US Near Patient HbA1c Testing Market (2015E): Percentage Share Breakdown of Revenues for Alere, Siemens and Others (includes corresponding Graph/Chart).....III-10
CGM Devices: Highly Consolidated Marketplace.....III-10
Table 50: Leading Companies in the US CGM Market (2014 & 2020P): Percentage Share Breakdown of Revenue for Abbott, DexCom, and Medtronic (includes corresponding Graph/Chart).....III-10
1$200
   Companies Focus on Research for Better Diabetes Diagnostics.....III-11
Drugstores Benefit from the Diabetic Care Category.....III-11
Integrated Products: An Upcoming Trend.....III-11
1$75
   Product Launches.....III-123$225
   Strategic Corporate Developments.....III-151$75
   Select Key Players.....III-168$600
   B. Market Analytics.....III-24
Table 51: US Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-24
1$200
   Table 52: US Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-251$200
   Table 53: US 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-261$200
   A. Market Analysis.....III-27
Current & Future Analysis.....III-27
Diabetes Statistics in Canada: Opportunity Indicator for Diabetes
  Diagnostics.....III-27
Table 54: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s).....III-27
1$200
   Table 55: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart).....III-28

Table 56: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-28
Aging Population: Key Opportunity Indicator.....III-28
Table 57: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-28
1$200
   B. Market Analytics.....III-29
Table 58: Canadian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-29
1$200
   Table 59: Canadian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-301$200
   Table 60: Canadian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-311$200
   A. Market Analysis.....III-32
Growing Aging Population Drives Diabetes Diagnostics Market.....III-32
Table 61: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-32
1$200
   Trends Influencing Diabetes Diagnostics Market.....III-33
Table 62: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-33
Product Launches.....III-33
1$200
   Select Key Players.....III-342$150
   B. Market Analytics.....III-36
Table 63: Japanese Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-36
1$200
   Table 64: Japanese Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-371$200
   Table 65: Japanese 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Diabetes Diagnostics Market in Europe – A Promising Outlook.....III-39
1$75
   Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption.....III-40
Diabetes Statistics in Europe.....III-40
1$75
   Table 66: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart).....III-411$200
   Table 67: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-421$200
   Reimbursement Scenario.....III-43
Product Launch.....III-43
1$75
   B. Market Analytics.....III-44
Table 68: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-44
1$200
   Table 69: European Historic Review for Diabetes Diagnostics by Geographic Region/ Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-451$200
   Table 70: European 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-461$200
   Table 71: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-471$200
   Table 72: European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-481$200
   Table 73: European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-491$200
   A. Market Analysis.....III-50
France: Diabetes & Aging Statistics.....III-50
Table 74: Diabetes Statistics in France (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-50

Table 75: Aging Population in France (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-50
1$200
   Product Launches.....III-51
Strategic Corporate Development.....III-51
Sanofi S.A.: A Major France-Based Company.....III-51
1$75
   B. Market Analytics.....III-52
Table 76: French Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-52
1$200
   Table 77: French Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   Table 78: French 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-541$200
   A. Market Analysis.....III-55
Germany: Diabetes & Aging Statistics.....III-55
Table 79: Diabetes Statistics in Germany (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-55

Table 80: Aging Population in Germany (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-55
1$200
   Strategic Corporate Developments.....III-56
Select Key Players.....III-56
2$150
   B. Market Analytics.....III-58
Table 81: German Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-58
1$200
   Table 82: German Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-591$200
   Table 83: German 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
Italy: Diabetes & Aging Statistics.....III-61
Table 84: Diabetes Statistics in Italy (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-61

Table 85: Aging Population in Italy (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-61
1$200
   B. Market Analytics.....III-62
Table 86: Italian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-62
1$200
   Table 87: Italian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-631$200
   Table 88: Italian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-641$200
   A. Market Analysis.....III-65
NHS England Launches Action for Diabetes Plan.....III-65
NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose
  Testing.....III-65
1$75
   Self-Monitoring Blood Glucose Meters Gain Popularity.....III-66
NICE Recommendations for Self-Monitoring Blood Glucose (SMBG).....III-66
1$75
   Diabetes Statistics & Management – An Insight.....III-67
Table 89: Diabetes Statistics in United Kingdom (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-67
1$200
   Table 90: Aging Population in the United Kingdom (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-68
Rising Obesity Cases – Increased Risk of Diabetes.....III-68
1$200
   Type 1 Diabetes in Children.....III-69
Table 91: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart).....III-69
Product Launches.....III-69
1$200
   Select Key Players.....III-702$150
   B. Market Analytics.....III-72
Table 92: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-72
1$200
   Table 93: UK Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-731$200
   Table 94: UK 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-741$200
   A. Market Analysis.....III-75
Spain: Diabetes & Aging Statistics.....III-75
Table 95: Diabetes Statistics in Spain (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-75

Table 96: Aging Population in Spain (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-75
1$200
   B. Market Analytics.....III-76
Table 97: Spanish Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-76
1$200
   Table 98: Spanish Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-771$200
   Table 99: Spanish 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
Russia: Diabetes & Aging Statistics.....III-79
Table 100: Diabetes Statistics in Russia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-79
1$200
   Table 101: Aging Population in Russia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-801$200
   B. Market Analytics.....III-81
Table 102: Russian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-81
1$200
   Table 103: Russian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-821$200
   Table 104: Russian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-831$200
   A. Market Analysis.....III-84
Product Launches.....III-84
Strategic Corporate Developments.....III-84
1$75
   Select Key Players.....III-853$225
   B. Market Analytics.....III-88
Table 105: Rest of European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-88
1$200
   Table 106: Rest of European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-891$200
   Table 107: Rest of European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-901$200
   A. Market Analysis.....III-91
Technological Integration: An Emerging Trend in the Asia-Pacific Medical Devices
  Market.....III-91
Public and Private Sector Diabetes Care.....III-91
Public Sector.....III-91
1$75
   Private Sector.....III-92
BGM Devices: Competitive Landscape.....III-92
Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth
  Opportunities.....III-92
1$75
   Table 108: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-931$200
   Table 109: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-941$200
   Table 110: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-951$200
   Table 111: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-96
Role of Healthcare Societies and Associations.....III-96
India.....III-96
1$200
   Bangladesh.....III-97
Western Pacific Declaration on Diabetes.....III-97
China.....III-97
China: Lower Penetration Offers High Growth Potential.....III-97
1$75
   Table 112: Leading Companies in the Chinese Glucose Meter Market (2015): Percentage Share Breakdown of Revenue for Abbott, Bayer, J&J, Omron, Roche, Sinocare & Yuyue (includes corresponding Graph/Chart).....III-98
Reimbursement of Diabetes Diagnostics in China (2015): Glucose Meters and
  Test Strips’ Reimbursement Status and Percentage.....III-98
Increasing Diabetes Incidence Remains Growth Driver.....III-98
1$200
   Table 113: Diabetes Statistics in China (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-991$200
   Key Opportunity Indicator: Aging Population.....III-100
Table 114: Aging Population in China (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-100
India.....III-100
Market Overview.....III-100
1$200
   Growth Stimulants & Challenges in a Nutshell.....III-101
HbA1c Testing on Growth Spree.....III-101
Most Glucose Meters in Indian Market Feature Imported Technology.....III-101
1$75
   ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology.....III-1021$75
   Market Restraints.....III-103
Rising Diabetes Cases – Opportunities for Diabetes Diagnostics.....III-103
1$75
   Table 115: Diabetes Statistics in India (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-104
Key Opportunity Indicator: Aging Population.....III-104
Table 116: Aging Population in India (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-104
1$200
   Australia.....III-105
Australia: An Insight into Diabetes Statistics.....III-105
Table 117: Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-105
1$200
   Table 118: Diabetes Statistics in Australia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-106
Key Opportunity Indicator: Aging Population Statistics in Rest of
  Asia-Pacific.....III-106
Table 119: Aging Population in Rest of Asia by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-106
1$200
   Product Launches.....III-107
Select Key Players.....III-107
2$150
   B. Market Analytics.....III-109
Table 120: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-109
1$200
   Table 121: Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region/ Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1101$200
   Table 122: Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1111$200
   Table 123: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-1121$200
   Table 124: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1131$200
   Table 125: Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1141$200
   A. Market Analysis.....III-115
Diabetes in Latin America – A Glance at Key Statistics.....III-115
1$75
   Table 126: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-1161$200
   Table 127: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1171$200
   Key Opportunity Indicator: Aging Population.....III-118
Table 128: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-118
1$200
   Table 129: Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-1191$200
   B. Market Analytics.....III-120
Table 130: Latin American Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-120
1$200
   Table 131: Latin American Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1211$200
   Table 132: Latin American 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1221$200
   A. Market Analysis.....III-123
Diabetes Statistics in Africa and the Middle East.....III-123
Table 133: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....III-123
1$200
   Table 134: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1241$200
   Table 135: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-1251$200
   Table 136: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1261$200
   Key Opportunity Indicator: Aging Population.....III-127
Table 137: Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-127
1$200
   Table 138: Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-128
Strategic Corporate Development.....III-128
Clinical-Stage Company Based in Israel - Integrity Applications.....III-128
1$200
   B. Market Analytics.....III-129
Table 139: Rest of World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-129
1$200
   Table 140: Rest of World Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1301$200
   Table 141: Rest of World 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1311$200
  
Total Companies Profiled: 58 (including Divisions/Subsidiaries - 75)

Region/Country Players

The United States 35 Canada 1 Japan 4 Europe 23 France 2 Germany 4 The United Kingdom 8 Italy 1 Rest of Europe 8 Asia-Pacific (Excluding Japan) 10 Middle-East 2
Click here to request a full table of contents and more details on this project.